The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting

Simple Summary In this monocentric retrospective analysis, the extent of resection of singular/solitary brain metastases has no impact on local recurrence and overall survival rates in patients receiving multidisciplinary adjuvant treatment. Since systemic disease progression is the leading cause of death, and an uncontrolled systemic disease status, along with adjuvant treatment, present independent predictors of overall survival, a comprehensive, multidisciplinary treatment concept is essential for patients with brain metastases. Abstract Background and Purpose: The value of gross-total surgical resection remains debatable in patients with brain metastases (BMs) as most patients succumb to systemic disease progression. In this study, we evaluated the impact of the extent of resection of singular/solitary BM on in-brain recurrence (iBR), focusing on local recurrence (LR) and overall survival (OS) in an interdisciplinary adjuvant treatment setting. Patients and Methods: In this monocentric retrospective analysis, we included patients receiving surgery of one BM and subsequent adjuvant treatment. A radiologist and a neurosurgeon determined in consensus the extent of resection based on magnetic resonance imaging. The OS was calculated using Kaplan–Meier estimates; prognostic factors for LR and OS were analysed by Log rank test and Cox proportional hazards. Results: We analyzed 197 patients. Gross-total resection was achieved in 123 (62.4%) patients. All patients were treated with adjuvant radiotherapy, and 130 (66.0%) received systemic treatment. Ninety-six (48.7%) patients showed iBR with an LR rate of 23.4%. LR was not significantly influenced by the extent of resection (p = 0.139) or any other parameter. The median OS after surgery was 18 (95%CI 12.5–23.5) months. In univariate analysis, the extent of resection did not influence OS (p = 0.6759), as opposed to adjuvant systemic treatment (p < 0.0001) and controlled systemic disease (p = 0.039). Systemic treatment and controlled disease status remained independent factors for OS (p < 0.0001 and p = 0.009, respectively). Conclusions: In this study, the extent of resection of BMs neither influenced the LR nor the OS of patients receiving interdisciplinary adjuvant treatment.

[1]  R. Goldbrunner,et al.  Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment , 2020, Cancer medicine.

[2]  W. Wick,et al.  Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee , 2020, BMC Cancer.

[3]  G. Reyes-Soto,et al.  Clinical manifestations and location of brain metastases as prognostic markers. , 2019, Current problems in cancer.

[4]  H. Steiger,et al.  Risk factors for in-brain local progression in elderly patients after resection of cerebral metastases , 2019, Scientific Reports.

[5]  P. Brastianos,et al.  Targeting Molecular Pathways in Intracranial Metastatic Disease , 2019, Front. Oncol..

[6]  J. Olson,et al.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Treatment Options for Adults With Multiple Metastatic Brain Tumors , 2019, Neurosurgery.

[7]  F. Poulsen,et al.  Early postoperative MRI after resection of brain metastases—complete tumour resection associated with prolonged survival , 2019, Acta Neurochirurgica.

[8]  S. Marnitz,et al.  Postoperative local fractionated radiotherapy for resected single brain metastases , 2018, Strahlentherapie und Onkologie.

[9]  D. Rodrigues,et al.  Analysis of survival in patients with brain metastases treated surgically: Impact of age, gender, oncologic status, chemotherapy, radiotherapy, number and localization of lesions, and primary cancer site. , 2018, Revista da Associacao Medica Brasileira.

[10]  B. Pintea,et al.  Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts , 2017, Radiation oncology.

[11]  Nicholas B. Levine,et al.  Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. , 2017, The Lancet. Oncology.

[12]  H. Igaki,et al.  Outcomes of Surgery followed by Local Brain Radiotherapy Compared with Surgery followed by Whole Brain Radiotherapy for Single Brain Metastasis , 2017, Tumori.

[13]  V. Venur,et al.  Targeted Therapies for Brain Metastases from Breast Cancer , 2016, International journal of molecular sciences.

[14]  D. Kondziolka,et al.  Resection Followed by Involved-Field Fractionated Radiotherapy in the Management of Single Brain Metastasis , 2015, Front. Oncol..

[15]  H. Steiger,et al.  Early postoperative magnet resonance tomography after resection of cerebral metastases , 2015, Acta Neurochirurgica.

[16]  H. Steiger,et al.  Incidence of local in-brain progression after supramarginal resection of cerebral metastases , 2015, Acta Neurochirurgica.

[17]  S. Chmura,et al.  Treatment of Brain Metastases , 2014, Oncology.

[18]  Frank Winkler,et al.  Invasion patterns in brain metastases of solid cancers. , 2013, Neuro-oncology.

[19]  J. Golfinos,et al.  Involved field radiation therapy after surgical resection of solitary brain metastases--mature results. , 2013, Neuro-oncology.

[20]  H. Steiger,et al.  The tumour is not enough or is it? Problems and new concepts in the surgery of cerebral metastases , 2013, Ecancermedicalscience.

[21]  R. Sawaya,et al.  The role of surgical resection in patients with brain metastases , 2013, Ecancermedicalscience.

[22]  Chae-Yong Kim,et al.  The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study , 2013, Acta Neurochirurgica.

[23]  G. Schackert,et al.  Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome , 2013, Acta Neurochirurgica.

[24]  O. Chinot,et al.  Recent trends in epidemiology of brain metastases: an overview. , 2012, Anticancer research.

[25]  D. Rades,et al.  Single brain metastasis: whole‐brain irradiation plus either radiosurgery or neurosurgical resection , 2012, Cancer.

[26]  T. Kayama,et al.  Comparison of clinical outcomes of surgery followed by local brain radiotherapy and surgery followed by whole brain radiotherapy in patients with single brain metastasis: single-center retrospective analysis. , 2011, International journal of radiation oncology, biology, physics.

[27]  Hui-Kuo Shu,et al.  Metastasis infiltration: an investigation of the postoperative brain-tumor interface. , 2011, International journal of radiation oncology, biology, physics.

[28]  Tarek Mekhail,et al.  Adjuvant Whole-Brain Radiotherapy Versus Observation after Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study , 2011, Current oncology reports.

[29]  Mark Bernstein,et al.  Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. , 2009, Journal of neurosurgery.

[30]  R. Sawaya,et al.  Management of brain metastases: the indispensable role of surgery , 2009, Journal of Neuro-Oncology.

[31]  J. Zo,et al.  Reduced local recurrence of a single brain metastasis through microscopic total resection. , 2009, Journal of neurosurgery.

[32]  S. Toms,et al.  RPA classification has prognostic significance for surgically resected single brain metastasis. , 2006, International journal of radiation oncology, biology, physics.

[33]  Philippe Lambin,et al.  A pathology-based substrate for target definition in radiosurgery of brain metastases. , 2006, International journal of radiation oncology, biology, physics.

[34]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[35]  T. Iizasa,et al.  Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. , 1999, Lung cancer.

[36]  O. Agboola,et al.  Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. , 1998, International journal of radiation oncology, biology, physics.

[37]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[38]  M. Burt,et al.  Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. , 1995, Journal of neurosurgery.

[39]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[40]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[41]  R. Andrews,et al.  Surgical resection of brain metastases from lung cancer , 2005, Acta Neurochirurgica.

[42]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.